Please use this identifier to cite or link to this item:
https://doi.org/10.1128/aac.02584-20
DC Field | Value | |
---|---|---|
dc.title | Epidemiology and transmission of carbapenemase-producing enterobacteriaceae in a health care network of an acute-care hospital and its affiliated intermediate- And long-term-care facilities in Singapore | |
dc.contributor.author | Aung, Aung-Hein | |
dc.contributor.author | Kanagasabai, Kala | |
dc.contributor.author | Koh, Jocelyn | |
dc.contributor.author | Hon, Pei-Yun | |
dc.contributor.author | Ang, Brenda | |
dc.contributor.author | Lye, David | |
dc.contributor.author | Chen, Swaine L. | |
dc.contributor.author | Chow, Angela | |
dc.date.accessioned | 2022-10-12T08:15:47Z | |
dc.date.available | 2022-10-12T08:15:47Z | |
dc.date.issued | 2021-07-16 | |
dc.identifier.citation | Aung, Aung-Hein, Kanagasabai, Kala, Koh, Jocelyn, Hon, Pei-Yun, Ang, Brenda, Lye, David, Chen, Swaine L., Chow, Angela (2021-07-16). Epidemiology and transmission of carbapenemase-producing enterobacteriaceae in a health care network of an acute-care hospital and its affiliated intermediate- And long-term-care facilities in Singapore. Antimicrobial Agents and Chemotherapy 65 (8) : e02584. ScholarBank@NUS Repository. https://doi.org/10.1128/aac.02584-20 | |
dc.identifier.issn | 0066-4804 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/232600 | |
dc.description.abstract | Movement of patients in a health care network poses challenges for the control of carbapenemase-producing Enterobacteriaceae (CPE). We aimed to identify intra- and interfacility transmission events and facility type-specific risk factors of CPE in an acute-care hospital (ACH) and its intermediate-term and long-term-care facilities (ILTCFs). Serial cross-sectional studies were conducted in June and July of 2014 to 2016 to screen for CPE. Whole-genome sequencing was done to identify strain relatedness and CPE genes (blaIMI, blaIMP-1, blaKPC-2, blaNDM-1, and blaOXA-48). Multivariable logistic regression models, stratified by facility type, were used to determine independent risk factors. Of 5,357 patients, half (55%) were from the ACH. CPE prevalence was 1.3% in the ACH and 0.7% in ILTCFs (P=0.029). After adjusting for sociodemographics, screening year, and facility type, the odds of CPE colonization increased significantly with a hospital stay of $3weeks (adjusted odds ratio [aOR], 2.67; 95% confidence interval [CI], 1.17 to 6.05), penicillin use (aOR, 3.00; 95% CI, 1.05 to 8.56), proton pump inhibitor use (aOR, 3.20; 95% CI, 1.05 to 9.80), dementia (aOR, 3.42; 95% CI, 1.38 to 8.49), connective tissue disease (aOR, 5.10; 95% CI, 1.19 to 21.81), and prior carbapenem-resistant Enterobacteriaceae (CRE) carriage (aOR, 109.02; 95% CI, 28.47 to 417.44) in the ACH. For ILTCFs, presence of wounds (aOR, 5.30; 95% CI, 1.01 to 27.72), respiratory procedures (aOR, 4.97; 95% CI, 1.09 to 22.71), vancomycin-resistant enterococcus carriage (aOR, 16.42; 95% CI, 1.52 to 177.48), and CRE carriage (aOR, 758.30; 95% CI, 33.86 to 16,982.52) showed significant association. Genomic analysis revealed only possible intra-ACH transmission and no evidence for ACH-to-ILTCF transmission. Although CPE colonization was predominantly in the ACH, risk factors varied between facilities. Targeted screening and precautionary measures are warranted. Copyright © 2021 Aung et al. | |
dc.publisher | American Society for Microbiology | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus OA2021 | |
dc.subject | Beta-lactam resistant | |
dc.subject | Bla | |
dc.subject | BlaIMI | |
dc.subject | BlaIMP-1 | |
dc.subject | BlaKPC-2 | |
dc.subject | BlaNDM-1 | |
dc.subject | BlaOXA-48 | |
dc.subject | Carbapenem-resistant Enterobacteriaceae | |
dc.subject | Carbapenemase-producing Enterobacteriaceae | |
dc.subject | Epidemiology | |
dc.subject | Health care facilities | |
dc.subject | Molecular epidemiology | |
dc.subject | Risk factors | |
dc.subject | Transmission | |
dc.type | Article | |
dc.contributor.department | MEDICINE | |
dc.contributor.department | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH | |
dc.description.doi | 10.1128/aac.02584-20 | |
dc.description.sourcetitle | Antimicrobial Agents and Chemotherapy | |
dc.description.volume | 65 | |
dc.description.issue | 8 | |
dc.description.page | e02584 | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1128_aac_02584-20.pdf | 829.28 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License